BCPC Quote, Financials, Valuation and Earnings

Friedman Industries has a net margin of 14.1% compared to Balchem's net margin of -0.63%. Balchem's return on equity of 11.16% beat Friedman Industries's return on equity of 6.32%.

Balchem has a consensus price target of --, signalling upside risk potential of 15.12%. On the other hand Friedman Industries has an analysts' consensus of -- which suggests that it could fall by --. Given that Balchem has higher upside potential than Friedman Industries, analysts believe Balchem is more attractive than Friedman Industries.

Balchem has a beta of 0.668, which suggesting that the stock is 33.165% less volatile than S&P 500. In comparison Friedman Industries has a beta of 1.410, suggesting its more volatile than the S&P 500 by 41.002%.

Balchem has a quarterly dividend of $0.79 per share corresponding to a yield of 0.48%. Friedman Industries offers a yield of 0.88% to investors and pays a quarterly dividend of $0.04 per share. Balchem pays 21.07% of its earnings as a dividend. Friedman Industries pays out 3.35% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Balchem quarterly revenues are $239.9M, which are larger than Friedman Industries quarterly revenues of $106.8M. Balchem's net income of $33.8M is higher than Friedman Industries's net income of -$675K. Notably, Balchem's price-to-earnings ratio is 44.44x while Friedman Industries's PE ratio is 13.97x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Balchem is 5.73x versus 0.24x for Friedman Industries. Usually stocks with elevated PS ratios are considered overvalued.

Innospec has a net margin of 14.1% compared to Balchem's net margin of 7.53%. Balchem's return on equity of 11.16% beat Innospec's return on equity of 12.17%.

Balchem has a consensus price target of --, signalling upside risk potential of 15.12%. On the other hand Innospec has an analysts' consensus of -- which suggests that it could grow by 19.82%. Given that Innospec has higher upside potential than Balchem, analysts believe Innospec is more attractive than Balchem.

Balchem has a beta of 0.668, which suggesting that the stock is 33.165% less volatile than S&P 500. In comparison Innospec has a beta of 1.086, suggesting its more volatile than the S&P 500 by 8.649%.

Balchem has a quarterly dividend of $0.79 per share corresponding to a yield of 0.48%. Innospec offers a yield of 1.42% to investors and pays a quarterly dividend of $0.79 per share. Balchem pays 21.07% of its earnings as a dividend. Innospec pays out 25.23% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Balchem quarterly revenues are $239.9M, which are smaller than Innospec quarterly revenues of $443.4M. Balchem's net income of $33.8M is higher than Innospec's net income of $33.4M. Notably, Balchem's price-to-earnings ratio is 44.44x while Innospec's PE ratio is 19.08x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Balchem is 5.73x versus 1.46x for Innospec. Usually stocks with elevated PS ratios are considered overvalued.

Paramount Gold Nevada has a net margin of 14.1% compared to Balchem's net margin of --. Balchem's return on equity of 11.16% beat Paramount Gold Nevada's return on equity of --.

Balchem has a consensus price target of --, signalling upside risk potential of 15.12%. On the other hand Paramount Gold Nevada has an analysts' consensus of -- which suggests that it could grow by 257.04%. Given that Paramount Gold Nevada has higher upside potential than Balchem, analysts believe Paramount Gold Nevada is more attractive than Balchem.

Balchem has a beta of 0.668, which suggesting that the stock is 33.165% less volatile than S&P 500. In comparison Paramount Gold Nevada has a beta of 1.854, suggesting its more volatile than the S&P 500 by 85.435%.

Balchem has a quarterly dividend of $0.79 per share corresponding to a yield of 0.48%. Paramount Gold Nevada offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Balchem pays 21.07% of its earnings as a dividend. Paramount Gold Nevada pays out -- of its earnings as a dividend. Balchem's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Balchem quarterly revenues are $239.9M, which are larger than Paramount Gold Nevada quarterly revenues of --. Balchem's net income of $33.8M is higher than Paramount Gold Nevada's net income of -$1.6M. Notably, Balchem's price-to-earnings ratio is 44.44x while Paramount Gold Nevada's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Balchem is 5.73x versus -- for Paramount Gold Nevada. Usually stocks with elevated PS ratios are considered overvalued.

Solitario Resources has a net margin of 14.1% compared to Balchem's net margin of --. Balchem's return on equity of 11.16% beat Solitario Resources's return on equity of --.

Balchem has a consensus price target of --, signalling upside risk potential of 15.12%. On the other hand Solitario Resources has an analysts' consensus of -- which suggests that it could grow by 155.97%. Given that Solitario Resources has higher upside potential than Balchem, analysts believe Solitario Resources is more attractive than Balchem.

Balchem has a beta of 0.668, which suggesting that the stock is 33.165% less volatile than S&P 500. In comparison Solitario Resources has a beta of 0.895, suggesting its less volatile than the S&P 500 by 10.55%.

Balchem has a quarterly dividend of $0.79 per share corresponding to a yield of 0.48%. Solitario Resources offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Balchem pays 21.07% of its earnings as a dividend. Solitario Resources pays out -- of its earnings as a dividend. Balchem's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Balchem quarterly revenues are $239.9M, which are larger than Solitario Resources quarterly revenues of --. Balchem's net income of $33.8M is higher than Solitario Resources's net income of -$2.3M. Notably, Balchem's price-to-earnings ratio is 44.44x while Solitario Resources's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Balchem is 5.73x versus -- for Solitario Resources. Usually stocks with elevated PS ratios are considered overvalued.